Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus for Cytokine Expression in SCD and ECD Kidney Transplants
NCT01663805Phase 4Unknown
- Start
- Jan 2012
- Primary completion
- Dec 2014
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of everolimus in kidney transplant rejection and delayed graft function (DGF). Status: unknown.
02
Drugs
everolimus
03
Conditions
kidney transplant rejectiondelayed graft function (DGF)
Beyond the preview
Go deeper on NCT01663805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01663805.